Key Dates

Related Announcements

• September 26, 2023     Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed). See NOFO PAR-23-301

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this notice is to inform potential applicants that the National Cancer Institute (NCI) will participate, effective immediately in PAR-23-301,  Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

The following changes and updates are made to PAR-23-301 (shown in bold italics) to reflect NCI’s participation:

Part 1. Overview Information, Participating Organization(s)

National Cancer Institute (NCI)

National Human Genome Research Institute (NHGRI)

Assistance Listing Number(s)

93.399;  93.172

Part 2. Full Text of Announcement, Section I. Funding Opportunity Description

Specific Areas of Research Interest

NCI is interested in applications that use systems epidemiology modeling or analysis approaches to advance the understanding of multilevel and dynamic factors that affect cancer risk and related outcomes, including factors that contribute to cancer disparities. For applications to be considered responsive to NCI interest, they will need to include all three of the following components: i) integrate germline genetic and environmental data, ii) utilize data across multiple scales (e.g., biological, social, or ecological organization), and iii) consider dynamism or multiple time points in the analysis.

Part 2. Full Text of Announcement, Section VII. Agency Contacts

Scientific/Research Contact(s)

Alexander Arguello, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 240-731-3753
Email: [email protected]

Leah Mechanic, PhD, MPH
National Cancer Institute (NCI)
Phone: (240) 276-6847
E-mail: [email protected]

Financial/Grants Management Contact(s)

Donna Morris
National Human Genome Research Institute (NHGRI)
Telephone: 301-827-2745
Email: [email protected]

Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 240-276-6277
Email: [email protected]

All other aspects of PAR-23-301 remain unchanged.

Inquiries

Please direct all inquiries to:

Leah Mechanic, PhD, MPH

National Cancer Institute (NCI)

Phone: (240) 276-6847

E-mail: [email protected]